000 01154 a2200289 4500
005 20250513215754.0
264 0 _c20000727
008 200007s 0 0 eng d
022 _a1355-8196
024 7 _a10.1177/135581960000500209
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlmarsdóttir, A B
245 0 0 _aCost containment of pharmaceutical use in Iceland: the impact of liberalization and user charges.
_h[electronic resource]
260 _bJournal of health services research & policy
_cApr 2000
300 _a109-13 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aCost Control
650 0 4 _aDrug Utilization Review
_xeconomics
650 0 4 _aIceland
650 0 4 _aInsurance, Health, Reimbursement
_xlegislation & jurisprudence
650 0 4 _aInsurance, Pharmaceutical Services
_xlegislation & jurisprudence
650 0 4 _aModels, Economic
700 1 _aMorgall, J M
700 1 _aGrímsson, A
773 0 _tJournal of health services research & policy
_gvol. 5
_gno. 2
_gp. 109-13
856 4 0 _uhttps://doi.org/10.1177/135581960000500209
_zAvailable from publisher's website
999 _c10896256
_d10896256